Business Description
Savior Lifetec Corp
ISIN : TW0004167002
Compare
Compare
Traded in other countries / regions
4167.Taiwan IPO Date
2015-09-08Description
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions such as the Americas, Asia, Taiwan, and Europe.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.39 | |||||
| Equity-to-Asset | 0.91 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | 0.65 | |||||
| Interest Coverage | 22.41 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 12.8 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17.1 | |||||
| 3-Year EBITDA Growth Rate | -24.1 | |||||
| 3-Year EPS without NRI Growth Rate | -52.6 | |||||
| 3-Year Book Growth Rate | 0.1 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.52 | |||||
| 9-Day RSI | 38.06 | |||||
| 14-Day RSI | 39.36 | |||||
| 6-1 Month Momentum % | -2.46 | |||||
| 12-1 Month Momentum % | 7.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.94 | |||||
| Quick Ratio | 13.08 | |||||
| Cash Ratio | 10.8 | |||||
| Days Inventory | 341.02 | |||||
| Days Sales Outstanding | 68.07 | |||||
| Days Payable | 16.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.42 | |||||
| Dividend Payout Ratio | 0.16 | |||||
| Forward Dividend Yield % | 0.42 | |||||
| 5-Year Yield-on-Cost % | 0.41 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 4.64 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.57 | |||||
| Operating Margin % | 14.3 | |||||
| Net Margin % | 14.29 | |||||
| FCF Margin % | 32.07 | |||||
| ROE % | 5.3 | |||||
| ROA % | 4.69 | |||||
| ROIC % | 8.06 | |||||
| ROC (Joel Greenblatt) % | 9.1 | |||||
| ROCE % | 5.04 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.19 | |||||
| PE Ratio without NRI | 37.31 | |||||
| Price-to-Owner-Earnings | 16.93 | |||||
| PS Ratio | 5.48 | |||||
| PB Ratio | 1.88 | |||||
| Price-to-Tangible-Book | 1.88 | |||||
| Price-to-Free-Cash-Flow | 16.98 | |||||
| Price-to-Operating-Cash-Flow | 14.38 | |||||
| EV-to-EBIT | 27.99 | |||||
| EV-to-EBITDA | 15.87 | |||||
| EV-to-Revenue | 4.1 | |||||
| EV-to-FCF | 12.96 | |||||
| Price-to-Projected-FCF | 1.76 | |||||
| Price-to-Median-PS-Value | 1.24 | |||||
| Price-to-Graham-Number | 1.76 | |||||
| Price-to-Net-Current-Asset-Value | 2.93 | |||||
| Price-to-Net-Cash | 5.42 | |||||
| Earnings Yield (Greenblatt) % | 3.57 | |||||
| FCF Yield % | 6.22 | |||||
| Forward Rate of Return (Yacktman) % | -4.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Savior Lifetec Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,258.368 | ||
| EPS (TTM) (NT$) | 0.55 | ||
| Beta | 0.26 | ||
| Volatility % | 33.51 | ||
| 14-Day RSI | 39.36 | ||
| 14-Day ATR (NT$) | 0.423194 | ||
| 20-Day SMA (NT$) | 20.9925 | ||
| 12-1 Month Momentum % | 7.65 | ||
| 52-Week Range (NT$) | 18.1 - 27.8 | ||
| Shares Outstanding (Mil) | 317.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Savior Lifetec Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Savior Lifetec Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Savior Lifetec Corp Frequently Asked Questions
What is Savior Lifetec Corp(ROCO:4167)'s stock price today?
The current price of ROCO:4167 is NT$20.45. The 52 week high of ROCO:4167 is NT$27.80 and 52 week low is NT$18.10.
When is next earnings date of Savior Lifetec Corp(ROCO:4167)?
The next earnings date of Savior Lifetec Corp(ROCO:4167) is .
Does Savior Lifetec Corp(ROCO:4167) pay dividends? If so, how much?
The Dividend Yield %  of Savior Lifetec Corp(ROCO:4167) is 0.42% (As of Today), Highest Dividend Payout Ratio of Savior Lifetec Corp(ROCO:4167) was 6.65. The lowest was 0.16. And the median was 3.94. The  Forward Dividend Yield % of Savior Lifetec Corp(ROCO:4167) is 0.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers